Loading...
Crucell and DSM Announce PER.C6® Licensing Agreement with Chiron
18-Aug-2005
Advertisement
Crucell N.V. and allied contract manufacturer DSM Biologics announced that they have signed a PER.C6® research license agreement for recombinant protein production with Chiron Corporation. This new agreement allows Chiron to evaluate the PER.C6® cell line for use in the manufacturing of Chiron's prophylactic hepatitis C vaccine, which is currently in phase I clinical trials. Financial details were not disclosed.